Literature DB >> 12553414

Developmental course of ADHD symptomatology during the transition from childhood to adolescence: a review with recommendations.

Michael T Willoughby1.   

Abstract

Although historically conceptualized as a disorder that was limited to males during middle childhood, ADHD is currently conceptualized as a chronic disorder that persists into adolescence and adulthood for both sexes. Nonetheless, the veracity of adult ADHD continues to be the source of debate. In order to frame this debate, research leading to the conceptualization of ADHD as a chronic disorder is reviewed. A distinction is made between the developmental outcomes versus the developmental course of ADHD. It is concluded that although childhood ADHD is associated with negative developmental outcomes in adolescence and adulthood, questions about the developmental course of ADHD remain. Although it appears that ADHD diminishes with advancing age, a number of methodological limitations prohibit firm conclusions. Recommendations for future studies are made with an emphasis on 1) overcoming extant methodological limitations in the literature and 2) the need for theoretically derived hypotheses regarding continuity and change in ADHD symptomatology over time.

Entities:  

Mesh:

Year:  2003        PMID: 12553414     DOI: 10.1111/1469-7610.t01-1-00104

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  44 in total

1.  Diagnosing ADHD in adolescence.

Authors:  Margaret H Sibley; William E Pelham; Brooke S G Molina; Elizabeth M Gnagy; Daniel A Waschbusch; Allison C Garefino; Aparajita B Kuriyan; Dara E Babinski; Kathryn M Karch
Journal:  J Consult Clin Psychol       Date:  2011-12-12

2.  ADHD in a representative sample of the Brazilian population: estimated prevalence and comparative adequacy of criteria between adolescents and adults according to the item response theory.

Authors:  Guilherme Polanczyk; Ronaldo Laranjeira; Marcos Zaleski; Ilana Pinsky; Raul Caetano; Luis Augusto Rohde
Journal:  Int J Methods Psychiatr Res       Date:  2010-09       Impact factor: 4.035

Review 3.  Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels?

Authors:  Dieter Baeyens; Herbert Roeyers; Johan Vande Walle
Journal:  Child Psychiatry Hum Dev       Date:  2006

Review 4.  A Developmental Psychopathology Perspective on ADHD and Comorbid Conditions: The Role of Emotion Regulation.

Authors:  Elizabeth A Steinberg; Deborah A G Drabick
Journal:  Child Psychiatry Hum Dev       Date:  2015-12

5.  Gestational and perinatal exposure to diazinon causes long-lasting neurobehavioral consequences in the rat.

Authors:  Andrew Hawkey; Erica Pippen; Hannah White; Joseph Kim; Eva Greengrove; Bruny Kenou; Zade Holloway; Edward D Levin
Journal:  Toxicology       Date:  2019-11-05       Impact factor: 4.221

6.  A mixture-model approach to linking ADHD to adolescent onset of illicit drug use.

Authors:  Patrick S Malone; Kathryn Van Eck; Kate Flory; Dorian A Lamis
Journal:  Dev Psychol       Date:  2010-11

7.  Examining the validity of ADHD as a diagnosis for adolescents with intellectual disabilities: clinical presentation.

Authors:  Cameron L Neece; Bruce L Baker; Keith Crnic; Jan Blacher
Journal:  J Abnorm Child Psychol       Date:  2013-05

8.  The emergence and stability of attention deficit hyperactivity disorder in boys with fragile X syndrome.

Authors:  M Grefer; K Flory; K Cornish; D Hatton; J Roberts
Journal:  J Intellect Disabil Res       Date:  2015-11-27

9.  Conners' Teacher Rating Scale for preschool children: a revised, brief, age-specific measure.

Authors:  David J Purpura; Christopher J Lonigan
Journal:  J Clin Child Adolesc Psychol       Date:  2009-03

10.  Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample.

Authors:  Joseph R Holbrook; Steven P Cuffe; Bo Cai; Susanna N Visser; Melinda S Forthofer; Matteo Bottai; Andrew Ortaglia; Robert E McKeown
Journal:  J Atten Disord       Date:  2014-07-03       Impact factor: 3.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.